Rosensweig Genomics Center

Rosensweig Genomics Center
Name	Rosensweig Genomics Center
Established	2004
Type	Research center
Director	Dr. Anya Petrova
Parent	University of California, San Francisco
Location	San Francisco, California, United States

Rosensweig Genomics Center is a premier research institution dedicated to advancing the field of genomics and its applications in biomedicine. Established in the early 21st century, it operates as a core facility within a major academic health sciences campus, providing state-of-the-art technological resources and fostering interdisciplinary collaboration. The center is named in recognition of a transformative philanthropic gift that enabled its creation and ongoing mission to decode the complexities of the human genome.

History and establishment

The center was founded in 2004 following a landmark donation from the Rosensweig Family Foundation, a philanthropic organization with a long-standing commitment to supporting medical research. This gift was instrumental in establishing a dedicated hub for genomic science at the University of California, San Francisco (UCSF), an institution renowned for its leadership in the health sciences. The establishment coincided with the completion of the Human Genome Project, a period of rapid expansion in genomic technologies and computational biology. Initial efforts focused on constructing core laboratory facilities and recruiting foundational faculty with expertise in molecular biology, bioinformatics, and genetic engineering.

Research focus and programs

Primary research at the center is organized around several key programs integrating DNA sequencing, functional genomics, and population genetics. A major focus is on cancer genomics, investigating the somatic mutations and epigenetic alterations that drive malignancies such as glioblastoma and pancreatic cancer. Another core program applies genome-wide association study (GWAS) methodologies to understand the genetic basis of complex diseases like Alzheimer's disease, type 2 diabetes, and rheumatoid arthritis. The center also hosts pioneering work in single-cell genomics, enabling the dissection of cellular heterogeneity in tissues from the brain and immune system. Additional initiatives explore the role of the microbiome in human health and the application of CRISPR-based screens for functional discovery.

Facilities and resources

The center houses a comprehensive suite of core facilities that provide critical services to the broader research community. These include a high-throughput DNA sequencing laboratory equipped with platforms from Illumina and Pacific Biosciences for both short-read and long-read applications. A dedicated bioinformatics core offers robust computational infrastructure, including high-performance computing clusters and secure data storage compliant with standards from the National Institutes of Health. Specialized laboratories support mass spectrometry for proteomics, advanced flow cytometry, and spatial transcriptomics imaging. The center also maintains a biobank of annotated clinical samples, collected under protocols approved by the UCSF Institutional Review Board.

Key personnel and leadership

The center is directed by Dr. Anya Petrova, a prominent geneticist known for her work on chromatin dynamics and gene regulation. The leadership team includes Associate Directors overseeing technology development, computational biology, and clinical genomics translation. Core faculty investigators, many of whom hold joint appointments in departments like Biochemistry and Biophysics, Neurology, and Pediatrics, lead independent research groups. Notable principal investigators have included recipients of prestigious awards such as the Howard Hughes Medical Institute Investigatorship and the National Academy of Sciences membership. The center also trains numerous postdoctoral researchers and graduate students affiliated with the UCSF Biomedical Sciences Graduate Program.

Collaborations and partnerships

The center maintains extensive collaborative networks with academic, clinical, and industry partners. Within UCSF, it works closely with the Helen Diller Family Comprehensive Cancer Center, the Institute for Neurodegenerative Diseases, and the Bakar Computational Health Sciences Institute. It is a participating member in several large-scale national consortia, including the Cancer Genome Atlas and the All of Us Research Program funded by the National Institutes of Health. International partnerships involve data-sharing initiatives with the Wellcome Sanger Institute in the United Kingdom and the RIKEN center in Japan. Strategic alliances with biotechnology firms, such as Genentech and 23andMe, facilitate the translation of genomic discoveries into diagnostic and therapeutic applications.

Impact and notable achievements

Research conducted has yielded significant contributions to genomic medicine and basic science. Investigators were among the first to characterize the mutational landscapes of several rare pediatric cancers, leading to new clinical trial designs. The center's population genomics studies have identified novel genetic risk loci for cardiovascular disease, influencing global risk assessment models. A landmark achievement was the development of a novel computational algorithm for interpreting non-coding genetic variation, now widely used in the field. Work from the center has been published in high-impact journals including Nature, Science, and Cell, and has informed clinical guidelines issued by the American College of Medical Genetics and Genomics. Its training programs have produced a generation of scientists now leading genomics initiatives at institutions worldwide.

Category:Genomics organizations Category:Research institutes in California Category:University of California, San Francisco